Klein Matthew B. sold PTCT
January 7, 2026 · Form 4 insider transaction
Klein Matthew B. sold 3,016 shares of PTC Therapeutics, Inc. at $77.48 per share, a transaction worth $233.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,016
Price
$77.48
Total value
$233.7K
InsiderKlein Matthew B.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 7, 2026
Filing dateJanuary 8, 2026
Shares owned after396,967
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a January 5, 2023 grant of 26,000 RSUs.